Juvenile Dermatomyositis
📧 Sign up to get email alerts when something new happens for Juvenile Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) [Phase 2]
Phase 2 clinical trial evaluating fatty acid supplementation for Dermatomyositis and Juvenile Dermatomyositis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy [Phase 2, Phase 3]
An open-label Phase 2/3 trial to evaluate the safety and efficacy of CABA-201 in active idiopathic inflammatory myopathy and related juvenil…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) [Phase 2]
A Phase 2 clinical trial evaluating baricitinib for new-onset juvenile dermatomyositis has completed.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome
This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders [Phase 1, Phase 2]
Descartes-08 by Cartesian Therapeutics is in Phase 1/2 and currently recruiting for pediatric/young adult trials in childhood-onset systemic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
A NIAMS-sponsored clinical trial update announcing studies on the natural history, pathogenesis, and outcomes of autoinflammatory diseases, …
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases [NA]
Completed study comparing two exercise training approaches (internal vs external focus) in children and adolescents with rheumatic diseases,…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Transition to Adulthood Through Coaching and Empowerment in Rheumatology [NA]
A completed study evaluating a coaching and empowerment program to help youths with juvenile rheumatic diseases transition to adulthood.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS other · 2026-01-20Clinical Trial Update: Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric Setting [NA]
A clinical trial update describes a pediatric study evaluating hypnotherapy to manage needle-related pain and anxiety during procedures; the…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases [Phase 1]
Phase 1 clinical trial evaluating a BCMA/CD70-targeted CAR-T therapy for refractory pediatric rheumatic diseases is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Fitness Integrative Training for Pediatric Rheumatology Disorders [NA]
The trial update reports completion of a study evaluating fitness integrative training for pediatric rheumatology disorders. The study inclu…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders [Phase 2]
This Phase 2 trial evaluating a COVID-19 booster vaccine in autoimmune-disease non-responders was terminated, with results posted on 2025-08…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress [NA]
Clinical trial status update about teams developing accessible mental health interventions for lupus erythematosus and dermatomyositis; the …
-
CLINICAL_TRIALS approval · 2025-01-17Clinical Trial Update: Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
The update notes that Eli Lilly's baricitinib has been approved for marketing for autoinflammatory syndromes including CANDLE, Juvenile Derm…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) [Phase 1]
A Phase 1 trial is evaluating a CD19-targeted universal CAR-T therapy (UCAR-T) for refractory juvenile dermatomyositis and is currently recr…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis [Phase 1]
A Phase 1 trial is evaluating CD19-targeted CAR-T therapy for refractory juvenile dermatomyositis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis [Phase 4]
A Phase 4 clinical trial update reports on the efficacy and safety of Acthar Gel (repository corticotropin injection) for refractory cutaneo…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis [Phase 3]
A five-year actively controlled Phase 3 trial in new onset juvenile dermatomyositis has completed enrollment with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis [NA]
A completed clinical trial assessed the effect of creatine supplementation on muscle function in children with juvenile dermatomyositis.
-
CLINICAL_TRIALS research · 2018-02-27Clinical Trial Update: Juvenile Dermatomyositis
This clinical trial update for Juvenile Dermatomyositis, sponsored by University Hospital in Strasbourg, France, shows an unknown status for…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease [Phase 4]
Phase 4 clinical trial evaluating the immune response to HPV vaccination in patients with autoimmune diseases. The study includes Juvenile I…
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: The CARRA Registry
The CARRA Registry study sponsored by Duke University has completed, documenting a broad range of juvenile rheumatic diseases, including Juv…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) [Phase 2]
Phase 2 trial evaluating rituximab for refractory adult and juvenile dermatomyositis and adult polymyositis; results have been posted.
-
CLINICAL_TRIALS research · 2012-01-16Clinical Trial Update: Creatine Supplementation in Pediatric Rheumatology [NA]
This entry notes a clinical trial evaluating creatine supplementation in pediatric rheumatology, including Juvenile Systemic Lupus Erythemat…